John Paul II Medical Research Institute the Home of Give Cures

Japan researchers conduct world's 1st transplant of iPS heart muscles

https://english.kyodonews.net/news/2020/01/47a1ba1f19f1-japan-researchers-conduct-worlds-1st-transplant-of-ips-heart-muscles.html

Japan researchers conduct world's 1st transplant of iPS heart muscles A research team led by a Japanese medical school professor says it has conducted the world's first transplant of heart muscle tissues using artificially derived stem cells known as iPS.

Japan univ. uses iPS cells to treat spinal cord injury for 1st time

https://english.kyodonews.net/news/2022/01/2e608f38826e-japan-univ-uses-ips-cells-to-treat-spinal-cord-injury-for-1st-time.html

Japan univ. uses iPS cells to treat spinal cord injury for 1st time Keio University in Tokyo says it has started the world's first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.

Japan team proves iPS-based cornea transplant safe in world-1st trial

https://english.kyodonews.net/news/2022/04/c8af6b7913b2-japan-team-proves-ips-based-cornea-transplant-safe-in-world-1st-trial.html

Japan team proves iPS-based cornea transplant safe in world-1st trial A Japanese university research team says it has concluded that the world's first clinical trial, spanning over years, transplanting corneal tissues derived from induced pluripotent stem cells, or iPS cells, into four almost-blind patients was safe and effective.

John Paul II Medical Research Institute - Donate Now

The 2022 Financial Goal for the "Campaign for Cures" Research for Developing Therapies for the Institute's Therapeutic Priorities
​
The financial needs for the "Campaign for Cures" for 2022 is $1,000,000. At the end of March, we have raised $100,000. We are pleased to report that we have achieved scientific milestones on time and within budget. These costs are high because the Institute needs to subcontract research to academic centers to conduct preclinical animal tests. These studies are government requirements. The objectives for 2022 is to raise private funding to help defray the cost of producing a first-in-class attenuated vaccine for COVID. The current EUA-approved COVID vaccines have failed in terms of efficacy and safety based on real-world experience. Additionally, these funds will also be used to cover the research costs of our adult stem cell research of our Therapeutic Priorities. The funds raised by the "Campaign for Cures" has achieved important research milestones. These research milestones will hopefully lead to more effective and moral vaccines, gene therapies, biologics and cell therapies that are free of aborted fetal cells and embryonic stem cells. Please join this important campaign by making a meaningful, tax-deductible contribution and earmark your donation towards our "Campaign for Cures" program. https://www.jp2mri.org/donate-now

John Paul II Medical Research Institute - Donate Now The John Paul II Medical Research Institute is a 501(c)(3) tax-exempt public charity, as defined by the Internal Revenue Service. Your gift to the John Paul II Medical Research Institute qualifies as a charitable deduction for federal tax purposes as permitted by law. The support of donors is at the...

PRESS RELEASE
March 8, 2022


The USPTO Issues a Patent to Cellular Engineering Technologies For Producing Safer Induced Pluripotent Stem Cells
The patent awards Cellular Engineering Technologies the intellectual property to develop, manufacture and commercialize induced pluripotent stem cells that are virus-free and carry a much lower cancer risk

Coralville, Iowa: Cellular Engineering Technologies (CET), Inc., an Iowa biotechnology company specializing in cell manufacturing and contract research services, today announced that it has received a patent from the United States Patent and Trademark Office for its virus-free and oncogene-free induced pluripotent stem cell (iPSC) technology. The iPSC technology which was previously published in Future Science Open Access and Regenerative Medicine was developed in collaboration with the John Paul II Medical Research Institute (JP2MRI), a non-profit organization. More recently, the National Institutes of Health awarded CET a SBIR grant to commercialize the technology to provide reproducible iPSC and differentiated neural stem cells that maintain pluripotency and genetic stability during large scale production.

The patent provides a new benchmark in pluripotent stem cell safety. Pluripotent stem cells carry an inherent neoplastic risk. Moreover, the industry desire to produce off-the-shelf allogeneic iPSC therapies that are immune-tolerant has the potential for inducing further harm by evading the patient’s innate immune system from unwanted immune-tolerant allogeneic neoplastic cells in a cell therapy. Thus, CET’s patent can realize the full potential of pluripotent stem cells as therapeutic products by reducing the inherent viral and neoplastic risk. This issued patent further strengthens CET’s intellectual property portfolio with its legacy expertise in human somatic stem cell manufacturing and bioprocessing; along with access to a recent worldwide license from ERS Genomics to utilizing CRISPR; and an exclusive license from JP2MRI’s pipeline of immortalized human stem cells that are designed for the bio-production of vaccines, allogeneic cell therapies (including CAR-T and CAR-NK cells), biologics and gene therapy vectors that together provide principled and scientific advantages over the current art. According to Dr. Alan Moy, CEO/CSO and Co-Founder of CET and Founder of JP2MRI, “CET’s objective is to expand contract manufacturing and research services for CET and JP2MRI’s therapeutic pipeline, as well as biopharmaceutical partners who wish to license CET’s pivotal intellectual property to advance their pipeline in cell therapy, biologics, vaccines and gene therapy vectors.”

Contact CET:
Anant Kamath
Chief Operating Officer
Tel: 319-665-3000
Email: [email protected]

About CET www.celleng-tech.com
Cellular Engineering Technologies (CET) is a biotechnology company that specializes in cell manufacturing and contract research services directed towards improving personalized and regenerative medicine. CET has expertise in cellular and tissue engineering, with a key focus on cell manufacturing and tissue culture media optimization, alongside research services that use non-embryonic human cells for less controversial bioprocessing. CET has the largest repository of human somatic stem cells and is the sole source manufacturer of some rare postnatal stem cells. CET employs a first-in-kind induced pluripotent stem cell (iPSC) technology that is virus-free and oncogene-free, with better predictability for drug discovery and safety in cell and gene therapy. CET distributes its products and services in Canada, United States, Asia, and Europe. For additional information please visit: www.celleng-tech.com.

Army doctor who became a nun sues Washington, DC over COVID jab mandate for health workers - LifeSite

A friend of mine whose constitutional rights are being violoated.- Alan Moy MD

https://www.lifesitenews.com/news/army-doctor-who-became-a-nun-sues-washington-dc-over-covid-jab-mandate-for-health-workers/?utm_source=top_news&utm_campaign=usa

Army doctor who became a nun sues Washington, DC over COVID jab mandate for health workers - LifeSite So far DC Health does not seem to have granted a single request for religious exemption from the vaccine mandate despite the paramount rights and guarantees under the Religious Freedom Restoration Act and the First Amendment to the United States Constitution.

Novavax COVID jab linked to aborted fetal cells through laboratory testing - LifeSite

https://www.lifesitenews.com/opinion/novavax-covid-jab-linked-to-aborted-fetal-cells-through-laboratory-testing/?utm_source=home_opinion&utm_campaign=catholic

Novavax COVID jab linked to aborted fetal cells through laboratory testing - LifeSite Despite Novavax's denial, an email reveals the company did indeed conduct confirmatory testing on fetal cell line HEK293 to compare the efficacy of its injection

Real world data contradicts the Vatican's 'common good' defense of the COVID jabs - LifeSite

https://www.lifesitenews.com/opinion/real-world-data-contradicts-the-vaticans-common-good-defense-of-the-covid-jabs/?utm_source=home_opinion&utm_campaign=catholic

Real world data contradicts the Vatican's 'common good' defense of the COVID jabs - LifeSite Stating that for one to get the COVID-19 vaccine is an act of love is to dismiss the relevant data of real-world experience that helps form one’s conscience; and to force one to get a COVID-19 vaccine against their well-formed conscience is contrary to love.

Paris - Police have joined the Protesters against Vaccine Mandates

https://www.youtube.com/watch?v=XsT4XPehygI

Paris - Police have joined the Protesters against Vaccine Mandates After months of clashing police in Paris have joined forces with protesters against vaccine mandates.

02 - 02 - 22 Dr. Alan Moy - Rare Disease Month And Cell Line Break Through

https://soundcloud.com/user-240811127/02-02-22-dr-alan-moy-rare-disease-month-and-cell-line-break-through?in=user-240811127/sets/01-31-22-spirit-mornings-week

02 - 02 - 22 Dr. Alan Moy - Rare Disease Month And Cell Line Break Through Encounter Jesus on Spirit Catholic Radio! We provide quality, Catholic radio to our listeners. Visit us online at spiritcatholicradio.com.

https://www.facebook.com/v2.2/dialog/share?app_id=19507961798&display=popup&redirect_uri=https%3A%2F%2Fsoundcloud.com%2Ffb_popup_callback.html&href=https%3A%2F%2Fsoundcloud.com%2Fuser-240811127%2F02-02-22-dr-alan-moy-rare-disease-month-and-cell-line-break-through%3Futm_source%3DFacebook%26utm_campaign%3Dsocial_sharing%26utm_medium%3Dwidget%26utm_content%3Dhttps%253A%2F%2Fsoundcloud.com%2Fuser-240811127%2F02-02-22-dr-alan-moy-rare-disease-month-and-cell-line-break-through

John Paul II Medical Research Institute (JP2MRI)

JP2MRI RAISED $802,000 OF ITS $1,000,000 2021 ANNUAL "CAMPAIGN FOR CURES" GOAL AT THE END OF 2021.

We thank all of those that supported the fundraising campaign last year to support development of one of the few gold standard therapeutic countermeasures for novel coronaviruses in the world, along with research to support its therapeutic priorities in neurodegenerative disease, cancer, rare disease and regenerative medicine for unmet chronic diseases.

John Paul II Medical Research Institute (JP2MRI) JP2MRI is a non-profit medical research institute devoted to find cures for medical diseases for the use of ethical adult stem cells.

John Paul II Medical Research Institute (JP2MRI)

JP2MRI HAS RAISED $775,000 OF ITS $1,000,000 ANNUAL "CAMPAIGN FOR CURES" AS OF TODAY.

For details of the "Campaign for Cures", please go to our website. Consider an end-of-the-year donation to develop one of the few gold standard therapeutic countermeasures for novel coronaviruses in the world independent of variant formation, along with research to support its therapeutic priorities in neurodegenerative disease, cancer, rare disease and regenerative medicine for unmet chronic diseases. Go to www.jp2mri.org. Share this information with your network.

John Paul II Medical Research Institute (JP2MRI) JP2MRI is a non-profit medical research institute devoted to find cures for medical diseases for the use of ethical adult stem cells.

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory - PubMed

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

https://pubmed.ncbi.nlm.nih.gov/34841223/

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory - PubMed Vaccines based on mRNA-containing lipid nanoparticles (LNPs) are a promising new platform used by two leading vaccines against COVID-19. Clinical trials and ongoing vaccinations present with varying degrees of protection levels and side effects. However, the drivers of the reported side effects rema...

Japan is rejecting mandatory COVID shots and discrimination against the unvaccinated - LifeSite

https://www.lifesitenews.com/opinion/japan-forbids-discrimination-against-those-who-reject-covid-jabs/?utm_source=top_news&utm_campaign=usa

Japan is rejecting mandatory COVID shots and discrimination against the unvaccinated - LifeSite We can contrast this with the vaccine mandate approach adopted in many other Western nations. The U.S. provides a case study in the anatomy of medical coercion exercised by a faceless bureaucratic network.

John Paul II Medical Research Institute - Donate Now

STRIPE DE-PLATFORMS JP2MRI

Over the past two months John Paul II Medical Research Institute has been working with our friends at LifeFunder to promote our vaccine development efforts through a crowdfunding campaign on their website. LifeFunder uses the Payment Processing Technology Company called Stripe to assist with credit card donations made for all campaigns set up on their website. This past week, our Institute was informed by Stripe that our account with them would be getting shut down because the Institute was operating a “crowdfunding” campaign and that such crowdfunding was against their company policies. This came as a surprise to our organization given that virtually all other campaigns on LifeFunder, as well as many other platforms, use Stripe to raise money for various critical services and needs through crowdfunding campaigns. JP2MRI was informed by Stripe that we could appeal the initial decision and did do so for a more thorough explanation. We were then informed by the representative at Stripe that our account was being closed because they had reviewed our website and found that what we were advocating for and trying to develop was against their company policies. We were shocked and disappointed to learn that the decision by Stripe was clearly politically motivated and based on the Institute’s scientific belief that the current vaccines on the market are not effective and needed a better, more ethical solution. Stripe has informed JP2MRI today that their decision is final. Consequently, since there is no way for donors to make donations to our campaign through LifeFunder, our campaign through LifeFunder will end as of today. Instead, we are asking all donors to make their donations to our Campaign for Cures by visiting our website directly at: https://www.jp2mri.org/donate-now

John Paul II Medical Research Institute - Donate Now The John Paul II Medical Research Institute is a 501(c)(3) tax-exempt public charity, as defined by the Internal Revenue Service. Your gift to the John Paul II Medical Research Institute qualifies as a charitable deduction for federal tax purposes as permitted by law. The support of donors is at the...

False Security, Why Vaccination Can’t End Pandemic with Dr. Paul Alexander

https://www.theepochtimes.com/false-security-why-vaccination-cant-end-pandemic-with-dr-paul-alexander_4150900.html?utm_source=News&utm_medium=email&utm_campaign=breaking-2021-12-11-4&est=ZGj2rWRvDng422PoVpW6swvMnFIhuUNU0STAguFBMZaFOQi66TXs7es%3D

False Security, Why Vaccination Can’t End Pandemic with Dr. Paul Alexander In this episode, we take a deep look at current COVID-19 mitigation policies and what lies behind them. ...

Local Catholic teen crowdfunds for abortion-free vaccines

https://catholicphilly.com/2021/12/news/local-news/local-catholic-teen-crowdfunds-for-abortion-free-vaccines/

Local Catholic teen crowdfunds for abortion-free vaccines Luke Luna, a student at Martin Saints Classical High School, is raising awareness of the John Paul II Medical Research Institute and its efforts to develop therapies consistent with Catholic teaching.

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

https://www.theepochtimes.com/dr-harvey-risch-hydroxychloroquine-ivermectin-and-other-therapeutics-highly-effective-in-early-covid-treatment_4131804.html

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment “These drugs have been suppressed… for reasons that have nothing to do with the science and the medicine.” ...

PART 2: Dr. Paul Alexander on the Politicization of Science and Why Healthy Children Shouldn’t Get the COVID Vaccine

https://www.theepochtimes.com/part-2-dr-paul-alexander-on-the-politicization-of-science-and-why-healthy-children-shouldnt-get-covid-vaccine_4120897.html

PART 2: Dr. Paul Alexander on the Politicization of Science and Why Healthy Children Shouldn’t Get the COVID Vaccine “If you say these vaccines are safe for my children … remove the liability protection.” Previously, in part one of ...

Could Boosters Backfire?—Dr. Paul Alexander on Booster Shots, Natural Immunity, and the Failures of Lockdowns | PART 1

https://www.theepochtimes.com/could-boosters-backfire-dr-paul-alexander-on-booster-shots-natural-immunity-and-the-failures-of-lockdowns-part-1_4115445.html?utm_source=Morningbrief&utm_medium=email&utm_campaign=mb-2021-11-23&est=EpxRkWeqwpVBZ8fMNiJJYXOiG9Si6%2FC5Gn%2BQXdV5wQcv2cmfC%2FSmlnM%3D

Informative interview.

Could Boosters Backfire?—Dr. Paul Alexander on Booster Shots, Natural Immunity, and the Failures of Lockdowns | PART 1 “We do not know how the immune system is going to react to so much boosting. Why? Because ...